Yelena Y. Janjigian, MD
Associate Attending Physician
Chief, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York
Yelena Y. Janjigian, MD, has disclosed that she has received consulting fees from AstraZeneca, Basilea, Bayer, Bristol-Myers Squibb, Daiichi Sankyo, Genentech/Roche, Imugene, Lilly, Merck, Merck Serono, RGENIX, Seagen, and Zymeworks; has received funds for research support paid to her institution from Bayer, Bristol-Myers Squibb, Lilly, Merck, and RGENIX; and has stock options from RGENIX.
Sandip P. Patel, MD
Division of Hematology and Medical Oncology
UC San Diego Moores Cancer Center
La Jolla, California
Sandip P. Patel, MD, has disclosed that he has received consulting fees from Amgen, AstraZeneca, Bristol-Myers Squibb, Certis, Genentech, Illumina, Lilly, Merck, Pfizer, Rakuten, and Tempus and funds for research support paid to his institution from Amgen, AstraZeneca/MedImmune, Bristol-Myers Squibb, Fate Therapeutics, Iovance, Lilly, Merck, Pfizer, Roche/Genentech, and SQZ Biotechnologies.